HBx represses RIZ1 expression by DNA methyltransferase 1 involvement in decreased miR-152 in hepatocellular carcinoma

Zhao,Zhujiang; Hu,Ying; Shen,Xiaohui; Lao,Yingbin; Zhang,Lihua; Qiu,Xuemei; Hu,Jiaojiao; Gong,Pihai; Cui,He; Lu,Sen; Zheng,Ying; Zhou,Menghan; Fan,Hong

doi:10.3892/or.2017.5518

HBx represses RIZ1 expression by DNA methyltransferase 1 involvement in decreased miR-152 in hepatocellular carcinoma

Authors:
- Zhujiang Zhao
- Ying Hu
- Xiaohui Shen
- Yingbin Lao
- Lihua Zhang
- Xuemei Qiu
- Jiaojiao Hu
- Pihai Gong
- He Cui
- Sen Lu
- Ying Zheng
- Menghan Zhou
- Hong Fan
View Affiliations

Affiliations: Department of Medical Genetics and Developmental Biology, Medical School of Southeast University and The Key Laboratory of Developmental Genes and Human Diseases, Ministry of Education, Southeast University, Nanjing, Jiangsu, P.R. China, Department of Pathology, Southeast University, Zhongda Hospital, Nanjing, Jiangsu, P.R. China, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, P.R. China
Published online on: March 21, 2017 https://doi.org/10.3892/or.2017.5518
Pages: 2811-2818

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Hepatitis B virus (HBV) is mainly suspected to promote hepatocellular carcinoma (HCC) development by epigenetic alteration. The HBV X protein (HBx) plays a key role in the molecular pathogenesis of HBV-related HCC. However, the mechanism of HBx-mediated hepatocarcinogenesis remains to be elucidated. RIZ1 gene, a candidate HCC suppressor gene, is frequently found to be hypermethylated and downregulated in HCC. In the present study, we show that the expression of RIZ1 was downregulated in 65% HCC tissues. Decreased expression of RIZ1 was restored by 5'-Aza in MHCC-97H HCC cell lines. HBx recombinant transfection increased DNMT1 expression level and suppressed RIZ1 expression. Moreover, knockdown of DNMT1 by siRNA restored RIZ1 expression in HCC cell SMMC-7721 and reduced methylated CpG sites of RIZ1. ChIP results showed that DNMT1 protein could bind to RIZ1 promoter, and this interaction was further enhanced with the transfected HBX recombinant. Moreover, miR-152 was decreased and involved in upregulation of DNMT1 in HBx transfected cells, at least partly, contributed to the epigenetic inactivation of RIZ1. Taken together, our data found that HBx repressed RIZ1 expression via DNMT1, which offered a new mechanism of RIZ1 inactivation in HCC, except for the widely known DNA methylation. These results enriched the epigenetic mechanism by which HBx contributes to pathogenesis of HBV-HCC.

View Figures

View References

1	Llovet JM, Burroughs A and Bruix J: Hepatocellular carcinoma. Lancet. 362:1907–1917. 2003. View Article : Google Scholar : PubMed/NCBI
2	Beasley RP, Hwang LY, Lin CC and Chien CS: Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan. Lancet. 2:1129–1133. 1981. View Article : Google Scholar : PubMed/NCBI
3	Wang Y, Cui F, Lv Y, Li C, Xu X, Deng C, Wang D, Sun Y, Hu G, Lang Z, et al: HBsAg and HBx knocked into the p21 locus causes hepatocellular carcinoma in mice. Hepatology. 39:318–324. 2004. View Article : Google Scholar : PubMed/NCBI
4	Soejima K, Fang W and Rollins BJ: DNA methyltransferase 3b contributes to oncogenic transformation induced by SV40T antigen and activated Ras. Oncogene. 22:4723–4733. 2003. View Article : Google Scholar : PubMed/NCBI
5	Park IY, Sohn BH, Yu E, Suh DJ, Chung YH, Lee JH, Surzycki SJ and Lee YI: Aberrant epigenetic modifications in hepatocarcinogenesis induced by hepatitis B virus X protein. Gastroenterology. 132:1476–1494. 2007. View Article : Google Scholar : PubMed/NCBI
6	Tsai CN, Tsai CL, Tse KP, Chang HY and Chang YS: The Epstein-Barr virus oncogene product, latent membrane protein 1, induces the downregulation of E-cadherin gene expression via activation of DNA methyltransferases. Proc Natl Acad Sci USA. 99:10084–10089. 2002. View Article : Google Scholar : PubMed/NCBI
7	Qiu X, Zhang L, Lu S, Song Y, Lao Y, Hu J and Fan H: Upregulation of DNMT1 mediated by HBx suppresses RASSF1A expression independent of DNA methylation. Oncol Rep. 31:202–208. 2014.PubMed/NCBI
8	Wang Y, Lu Y, Toh ST, Sung WK, Tan P, Chow P, Chung AY, Jooi LL and Lee CG: Lethal-7 is down-regulated by the hepatitis B virus×protein and targets signal transducer and activator of transcription 3. J Hepatol. 53:57–66. 2010. View Article : Google Scholar : PubMed/NCBI
9	Murakami Y, Yasuda T, Saigo K, Urashima T, Toyoda H, Okanoue T and Shimotohno K: Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. Oncogene. 25:2537–2545. 2006. View Article : Google Scholar : PubMed/NCBI
10	Lin L, Yin X, Hu X, Wang Q and Zheng L: The impact of hepatitis B virus×protein and microRNAs in hepatocellular carcinoma: A comprehensive analysis. Tumour Biol. 35:11695–11700. 2014. View Article : Google Scholar : PubMed/NCBI
11	Qiu X, Dong S, Qiao F, Lu S, Song Y, Lao Y, Li Y, Zeng T, Hu J, Zhang L, et al: HBx-mediated miR-21 upregulation represses tumor-suppressor function of PDCD4 in hepatocellular carcinoma. Oncogene. 32:3296–3305. 2013. View Article : Google Scholar : PubMed/NCBI
12	Buyse IM, Shao G and Huang S: The retinoblastoma protein binds to RIZ, a zinc-finger protein that shares an epitope with the adenovirus E1A protein. Proc Natl Acad Sci USA. 92:4467–4471. 1995. View Article : Google Scholar : PubMed/NCBI
13	Liu ZY, Wang JY, Liu HH, Ma XM, Wang CL, Zhang XP, Tao YQ, Lu YC, Liao JC and Hu GH: Retinoblastoma protein-interacting zinc-finger gene 1 (RIZ1) dysregulation in human malignant meningiomas. Oncogene. 32:1216–1222. 2013. View Article : Google Scholar : PubMed/NCBI
14	Suzuki M, Shigematsu H, Shivapurkar N, Reddy J, Miyajima K, Takahashi T, Gazdar AF and Frenkel EP: Methylation of apoptosis related genes in the pathogenesis and prognosis of prostate cancer. Cancer Lett. 242:222–230. 2006. View Article : Google Scholar : PubMed/NCBI
15	Fang W, Piao Z, Simon D, Sheu JC and Huang S: Mapping of a minimal deleted region in human hepatocellular carcinoma to 1p36.13-p36.23 and mutational analysis of the RIZ (PRDM2) gene localized to the region. Genes Chromosomes Cancer. 28:269–275. 2000. View Article : Google Scholar : PubMed/NCBI
16	Tokumaru Y, Nomoto S, Jerónimo C, Henrique R, Harden S, Trink B and Sidransky D: Biallelic inactivation of the RIZ1 gene in human gastric cancer. Oncogene. 22:6954–6958. 2003. View Article : Google Scholar : PubMed/NCBI
17	Oshimo Y, Oue N, Mitani Y, Nakayama H, Kitadai Y, Yoshida K, Chayama K and Yasui W: Frequent epigenetic inactivation of RIZ1 by promoter hypermethylation in human gastric carcinoma. Int J Cancer. 110:212–218. 2004. View Article : Google Scholar : PubMed/NCBI
18	Zhang C, Li H, Wang Y, Liu W, Zhang Q, Zhang T, Zhang X, Han B and Zhou G: Epigenetic inactivation of the tumor suppressor gene RIZ1 in hepatocellular carcinoma involves both DNA methylation and histone modifications. J Hepatol. 53:889–895. 2010. View Article : Google Scholar : PubMed/NCBI
19	Nishida N, Nagasaka T, Nishimura T, Ikai I, Boland CR and Goel A: Aberrant methylation of multiple tumor suppressor genes in aging liver, chronic hepatitis, and hepatocellular carcinoma. Hepatology. 47:908–918. 2008. View Article : Google Scholar : PubMed/NCBI
20	Fan H, Liu D, Qiu X, Qiao F, Wu Q, Su X, Zhang F, Song Y, Zhao Z and Xie W: A functional polymorphism in the DNA methyltransferase-3A promoter modifies the susceptibility in gastric cancer but not in esophageal carcinoma. BMC Med. 8:122010. View Article : Google Scholar : PubMed/NCBI
21	Chappell G, Kutanzi K, Uehara T, Tryndyak V, Hong HH, Hoenerhoff M, Beland FA, Rusyn I and Pogribny IP: Genetic and epigenetic changes in fibrosis-associated hepatocarcinogenesis in mice. Int J Cancer. 134:2778–2788. 2014. View Article : Google Scholar : PubMed/NCBI
22	Hutajulu SH, Indrasari SR, Indrawati LP, Harijadi A, Duin S, Haryana SM, Steenbergen RD, Greijer AE and Middeldorp JM: Epigenetic markers for early detection of nasopharyngeal carcinoma in a high risk population. Mol Cancer. 10:482011. View Article : Google Scholar : PubMed/NCBI
23	Mori N, Yoshinaga K, Tomita K, Ohwashi M, Kondoh T, Shimura H, Wang YH, Shiseki M, Okada M and Motoji T: Aberrant methylation of the RIZ1 gene in myelodysplastic syndrome and acute myeloid leukemia. Leuk Res. 35:516–521. 2011. View Article : Google Scholar : PubMed/NCBI
24	Zhang X, Liu S, Hu T, Liu S, He Y and Sun S: Up-regulated microRNA-143 transcribed by nuclear factor kappa B enhances hepatocarcinoma metastasis by repressing fibronectin expression. Hepatology. 50:490–499. 2009. View Article : Google Scholar : PubMed/NCBI
25	Kong G, Zhang J, Zhang S, Shan C, Ye L and Zhang X: Upregulated microRNA-29a by hepatitis B virus X protein enhances hepatoma cell migration by targeting PTEN in cell culture model. PLoS One. 6:e195182011. View Article : Google Scholar : PubMed/NCBI
26	Xiang Y, Ma N, Wang D, Zhang Y, Zhou J, Wu G, Zhao R, Huang H, Wang X, Qiao Y, et al: MiR-152 and miR-185 co-contribute to ovarian cancer cells cisplatin sensitivity by targeting DNMT1 directly: A novel epigenetic therapy independent of decitabine. Oncogene. 33:378–386. 2014. View Article : Google Scholar : PubMed/NCBI
27	Ji W, Yang L, Yuan J, Yang L, Zhang M, Qi D, Duan X, Xuan A, Zhang W, Lu J, et al: MicroRNA-152 targets DNA methyltransferase 1 in NiS-transformed cells via a feedback mechanism. Carcinogenesis. 34:446–453. 2013. View Article : Google Scholar : PubMed/NCBI
28	Huang J, Wang Y, Guo Y and Sun S: Down-regulated microRNA-152 induces aberrant DNA methylation in hepatitis B virus-related hepatocellular carcinoma by targeting DNA methyltransferase 1. Hepatology. 52:60–70. 2010. View Article : Google Scholar : PubMed/NCBI
29	Du Y, Carling T, Fang W, Piao Z, Sheu JC and Huang S: Hypermethylation in human cancers of the RIZ1 tumor suppressor gene, a member of a histone/protein methyltransferase superfamily. Cancer Res. 61:8094–8099. 2001.PubMed/NCBI
30	Abbondanza C, de Nigris F, De Rosa C, Rossiello R, Puca GA and Napoli C: Silencing of YY1 downregulates RIZ1 promoter in human osteosarcoma. Oncol Res. 17:33–41. 2008.PubMed/NCBI
31	Cheng HY, Gao Y and Lou G: DNA methylation of the RIZ1 tumor suppressor gene plays an important role in the tumorigenesis of cervical cancer. Eur J Med Res. 15:20–24. 2010. View Article : Google Scholar : PubMed/NCBI
32	Dong SW, Zhang P, Liu YM, Cui YT, Wang S, Liang SJ, He Z, Sun P and Wang YG: Study on RIZ1 gene promoter methylation status in human esophageal squamous cell carcinoma. World J Gastroenterol. 18:576–582. 2012. View Article : Google Scholar : PubMed/NCBI
33	Zhang C, Zhu Q, He H, Jiang L, Qiang Q, Hu L, Hu G, Jiang Y, Ding X and Lu Y: RIZ1: A potential tumor suppressor in glioma. BMC Cancer. 15:9902015. View Article : Google Scholar : PubMed/NCBI
34	Varnholt H, Drebber U, Schulze F, Wedemeyer I, Schirmacher P, Dienes HP and Odenthal M: MicroRNA gene expression profile of hepatitis C virus-associated hepatocellular carcinoma. Hepatology. 47:1223–1232. 2008. View Article : Google Scholar : PubMed/NCBI
35	Ladeiro Y, Couchy G, Balabaud C, Bioulac-Sage P, Pelletier L, Rebouissou S and Zucman-Rossi J: MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations. Hepatology. 47:1955–1963. 2008. View Article : Google Scholar : PubMed/NCBI